Date
27 September 2021
Governments fall behind in race to stem antimicrobial resistance
Clive Cookson for Financial Times writes about the looming human and financial cost posed by antimicrobial resistance.
In the article, Cookson explores the threat that antimicrobial resistance poses and investigates the consequences of delayed action in curbing AMR, noting that "without decisive action, there could be 10m deaths a year due to AMR by 2050 — and a cumulative cost to the global economy of $100tn."
Along with the World Health Organization’s annual Antibacterial Pipeline Report and the new AMR Preparedness Index, Cookson references the Access to Medicine Foundation's latest research, part of the Antimicrobial Resistance Benchmark, and the report's findings regarding the "valleys of death" that small drug-makers often face in their efforts to bring new antibiotics to market.